Home
About Us
Leadership Team
news
Careers
facility
Contact Us
news
Careers
facility
Contact Us
Home
About Us
Leadership Team
CAREERS
You are here
Home
» News
News
Resilience Receives USD $164 Million Investment from the Government of Canada to Modernize and Expand Its Ontario Biomanufacturing Site, Improving Pandemic Preparedness
06/03/2021
Therapure Biomanufacturing Signs Manufacturing Deal With VBI Vaccines for Coronavirus Vaccine Candidates
08/18/2020
Therapure Biomanufacturing Announces U.S. FDA Approval for Manufacturing of its Partner Insmed’s ARIKAYCE®
10/04/2018
Therapure Biopharma Inc. Wins the Mississauga Board of Trade’s 2017 Business Awards of Excellence
12/04/2017
Therapure Biopharma Inc. Announces Spin Off and Sale of Contract Development and Manufacturing Business for US$290 Million
09/06/2017
For a third consecutive year Therapure Biopharma Inc. ranks in the PROFIT 500 list of the Fastest-Growing Companies in Canada and ranks 10th in the GTA manufacturing sector (2nd largest employer).
05/05/2017
Therapure Biomanufacturing Receives 2017 CMO Leadership Individual Attribute Awards for Capabilities and Staff Characteristics
03/24/2017
Therapure Biopharma Inc. welcomes delegation from all three levels of government to its state-of-the-art facility
05/10/2016
Therapure Biopharma Inc. Postpones Initial Public Offering
02/09/2016
Therapure Biopharma Inc. Files Preliminary Prospectus for Initial Public Offering
11/26/2015
Pages
1
2
3
4
5
6
7
next ›
last »